Published in Vaccine on May 14, 2001
Staphylococcal biofilms. Curr Top Microbiol Immunol (2008) 4.26
Comparative opsonic and protective activities of Staphylococcus aureus conjugate vaccines containing native or deacetylated Staphylococcal Poly-N-acetyl-beta-(1-6)-glucosamine. Infect Immun (2005) 2.37
Truncation of fibronectin-binding proteins in Staphylococcus aureus strain Newman leads to deficient adherence and host cell invasion due to loss of the cell wall anchor function. Infect Immun (2004) 1.83
Identification of in vivo expressed vaccine candidate antigens from Staphylococcus aureus. Proc Natl Acad Sci U S A (2002) 1.75
Characterization of a protective monoclonal antibody recognizing Staphylococcus aureus MSCRAMM protein clumping factor A. Infect Immun (2003) 1.67
Comparison of antibody repertoires against Staphylococcus aureus in healthy individuals and in acutely infected patients. Clin Diagn Lab Immunol (2005) 1.60
Characterization of the opsonic and protective activity against Staphylococcus aureus of fully human monoclonal antibodies specific for the bacterial surface polysaccharide poly-N-acetylglucosamine. Infect Immun (2006) 1.52
Plant-derived virus-like particles as vaccines. Hum Vaccin Immunother (2012) 1.18
Human immune proteome in experimental colonization with Staphylococcus aureus. Clin Vaccine Immunol (2009) 1.09
Multicenter evaluation of the clinical outcomes of daptomycin with and without concomitant β-lactams in patients with Staphylococcus aureus bacteremia and mild to moderate renal impairment. Antimicrob Agents Chemother (2012) 1.07
Interaction of Cowpea mosaic virus (CPMV) nanoparticles with antigen presenting cells in vitro and in vivo. PLoS One (2009) 1.05
Antibody responses in patients with invasive Staphylococcus aureus infections. Eur J Clin Microbiol Infect Dis (2010) 0.97
The malate synthase of Paracoccidioides brasiliensis is a linked surface protein that behaves as an anchorless adhesin. BMC Microbiol (2009) 0.95
Cowpea mosaic virus capsid: a promising carrier for the development of carbohydrate based antitumor vaccines. Chemistry (2008) 0.92
Evaluation of clumping factor A binding region A in a subunit vaccine against Staphylococcus aureus-induced mastitis in mice. Clin Vaccine Immunol (2010) 0.85
Subviral particle as vaccine and vaccine platform. Curr Opin Virol (2014) 0.83
CD4 T cell antigens from Staphylococcus aureus Newman strain identified following immunization with heat-killed bacteria. Clin Vaccine Immunol (2012) 0.82
Progress in the development of effective vaccines to prevent selected gram-positive bacterial infections. Am J Med Sci (2010) 0.81
Evaluation of a novel chimeric B cell epitope-based vaccine against mastitis induced by either Streptococcus agalactiae or Staphylococcus aureus in mice. Clin Vaccine Immunol (2011) 0.79
Plant Viruses as Nanoparticle-Based Vaccines and Adjuvants. Vaccines (Basel) (2015) 0.79
Virus-Based Nanoparticles as Versatile Nanomachines. Annu Rev Virol (2015) 0.78
Immune response to a potyvirus with exposed amino groups available for chemical conjugation. Virol J (2012) 0.78
Complement activation influences Staphylococcus aureus adherence to endothelial cells. Infect Immun (2003) 0.77
Cell membrane-derived nanomaterials for biomedical applications. Biomaterials (2017) 0.76
Identification of the immunodominant regions of Staphylococcus aureus fibronectin-binding protein A. PLoS One (2014) 0.75
Antiphagocytic function of an IgG glycosyl hydrolase from Streptococcus equi subsp. equi and its use as a vaccine component. Infect Immun (2012) 0.75
Escherichia coli outer membrane protein F (OmpF): an immunogenic protein induces cross-reactive antibodies against Escherichia coli and Shigella. AMB Express (2017) 0.75
Development of Antistaphylococcal Vaccines. Curr Infect Dis Rep (2001) 0.75
IL-17A plays an important role in protection induced by vaccination with fibronectin-binding domain of fibronectin-binding protein A against Staphylococcus aureus infection. Med Microbiol Immunol (2017) 0.75
Injury-related fatalities in China: an under-recognised public-health problem. Lancet (2008) 2.99
Priming for enhanced alveolar fibrin deposition after hemorrhagic shock: role of tumor necrosis factor. Am J Respir Cell Mol Biol (2000) 2.43
Do pulmonary radiographic findings at presentation predict mortality in patients with community-acquired pneumonia? Arch Intern Med (1996) 2.29
Structure of the IgG-binding regions of streptococcal protein G. EMBO J (1986) 2.20
A fibrinogen-binding protein of Staphylococcus epidermidis. Infect Immun (1998) 2.06
Anti-CD44 treatment abrogates tissue oedema and leukocyte infiltration in murine arthritis. Nat Med (1995) 2.05
Expression of collagen-binding protein and types 5 and 8 capsular polysaccharide in clinical isolates of Staphylococcus aureus. J Infect Dis (1997) 1.96
Collagen binding of Staphylococcus aureus is a virulence factor in experimental endocarditis. J Infect Dis (1996) 1.94
Expression of and cytokine activation by Escherichia coli curli fibers in human sepsis. J Infect Dis (2000) 1.80
Cloning and characterization of a gene for a 19 kDa fibrinogen-binding protein from Staphylococcus aureus. Mol Microbiol (1994) 1.77
Evidence for three different fibrinogen-binding proteins with unique properties from Staphylococcus aureus strain Newman. Microb Pathog (1992) 1.76
Adherence of Staphylococcus aureus is enhanced by an endogenous secreted protein with broad binding activity. J Bacteriol (1999) 1.69
Hazardous chemicals: psychological dimensions of the health sequelae of a community exposure in Texas. J Epidemiol Community Health (1994) 1.66
Immunogenicity of peptides derived from a fibronectin-binding protein of S. aureus expressed on two different plant viruses. Vaccine (1999) 1.63
Efficacy trial of Vi polysaccharide vaccine against typhoid fever in south-western China. Bull World Health Organ (2001) 1.63
Cloning, sequencing and expression of subtilisin Carlsberg from Bacillus licheniformis. Nucleic Acids Res (1985) 1.61
Fibrinogen-binding protein/clumping factor from Staphylococcus aureus. Infect Immun (1989) 1.56
Influence of age on symptoms at presentation in patients with community-acquired pneumonia. Arch Intern Med (1997) 1.54
The hospital admission decision for patients with community-acquired pneumonia. Results from the pneumonia Patient Outcomes Research Team cohort study. Arch Intern Med (1997) 1.50
Interobserver reliability of the chest radiograph in community-acquired pneumonia. PORT Investigators. Chest (1996) 1.49
Lack of the extracellular 19-kilodalton fibrinogen-binding protein from Staphylococcus aureus decreases virulence in experimental wound infection. Infect Immun (1996) 1.46
Radiographic assessment of congenital talipes equinovarus: strapping versus forced dorsiflexion. J Orthop Surg (Hong Kong) (2005) 1.44
Human cervical ripening, an inflammatory process mediated by cytokines. Mol Hum Reprod (2000) 1.40
Immunization with fibronectin binding protein from Staphylococcus aureus protects against experimental endocarditis in rats. Microb Pathog (1993) 1.40
Immunomodulatory effects of hypertonic resuscitation on the development of lung inflammation following hemorrhagic shock. J Immunol (1998) 1.36
Nucleotide sequence of rfaI and rfaJ genes encoding lipopolysaccharide glycosyl transferases from Salmonella typhimurium. Nucleic Acids Res (1990) 1.33
Multiple binding sites in the interaction between an extracellular fibrinogen-binding protein from Staphylococcus aureus and fibrinogen. J Biol Chem (1998) 1.32
Usefulness of echocardiographic intrapericardial abnormalities in the diagnosis of tuberculous pericardial effusion. Am J Cardiol (2001) 1.31
uvrA is an acid-inducible gene involved in the adaptive response to low pH in Streptococcus mutans. J Bacteriol (2001) 1.30
Nutritional influences on biofilm development. Adv Dent Res (1997) 1.27
Deletion mutants of temperate Bacillus subtilis bacteriophage phi105. Mol Gen Genet (1977) 1.26
Detachment of Streptococcus mutans biofilm cells by an endogenous enzymatic activity. Infect Immun (1996) 1.25
Increased production of malondialdehyde in patients with HIV infection. Scand J Infect Dis (1988) 1.23
Preferences for home vs hospital care among low-risk patients with community-acquired pneumonia. Arch Intern Med (1996) 1.22
Effect of Brucella abortus lipopolysaccharide on oxidative metabolism and lysozyme release by human neutrophils. Infect Immun (1992) 1.20
CHD and its risk factors in the People's Republic of China. Int J Epidemiol (1989) 1.19
Tracheobronchial clearance in patients with influenza. Am Rev Respir Dis (1973) 1.14
Lack of fbe, the gene for a fibrinogen-binding protein from Staphylococcus epidermidis, reduces its adherence to fibrinogen coated surfaces. Microb Pathog (2001) 1.13
Treatment of bacterial vaginosis with lactobacilli. Sex Transm Dis (1992) 1.11
Elevated cytokine levels in tracheobronchial aspirate fluids from ventilator treated neonates with bronchopulmonary dysplasia. Eur J Pediatr (1996) 1.10
Vaccination with Staphylococcus aureus fibrinogen binding proteins (FgBPs) reduces colonisation of S. aureus in a mouse mastitis model. FEMS Immunol Med Microbiol (1994) 1.10
Evaluation of numerical typing systems for Escherichia coli using the API 50 CH and the PhP-EC systems as models. Epidemiol Infect (1990) 1.09
Simulated microgravity inhibits the proliferation and osteogenesis of rat bone marrow mesenchymal stem cells. Cell Prolif (2007) 1.09
Early increase of TNF alpha and IL-6 in tracheobronchial aspirate fluid indicator of subsequent chronic lung disease in preterm infants. Arch Dis Child Fetal Neonatal Ed (1997) 1.08
Safety assessment and dose selection for first-in-human clinical trials with immunomodulatory monoclonal antibodies. Clin Pharmacol Ther (2009) 1.07
Functional studies of a fibrinogen binding protein from Staphylococcus epidermidis. Infect Immun (1999) 1.07
Interleukin-6 and interleukin-8 in serum and urine in patients with acute pyelonephritis in relation to bacterial-virulence-associated traits and renal function. Nephron (1994) 1.05
Rebinding of extracellular adherence protein Eap to Staphylococcus aureus can occur through a surface-bound neutral phosphatase. J Bacteriol (2001) 1.05
Extracellular fibrinogen-binding protein, Efb, from Staphylococcus aureus blocks platelet aggregation due to its binding to the alpha-chain. J Biol Chem (2001) 1.04
Gastrointestinal motility enhancing effect of ginger and its active constituents. Chem Pharm Bull (Tokyo) (1990) 1.03
Vaccination against Staphylococcus aureus mastitis: immunological response of mice vaccinated with fibronectin-binding protein (FnBP-A) to challenge with S. aureus. Vaccine (1994) 1.02
Glove punctures in orthopaedic surgery. Int Orthop (2003) 1.02
Ureaplasma urealyticum-induced production of proinflammatory cytokines by macrophages. Pediatr Res (2000) 1.01
Collagen and fibronectin binding in experimental staphylococcal osteomyelitis. Clin Orthop Relat Res (2001) 1.01
Diffuse idiopathic skeletal hyperostosis with cervical spinal cord injury -a report of 3 cases and a literature review. Ann Acad Med Singapore (2005) 1.00
A proteoglycan (aggrecan)-specific T cell hybridoma induces arthritis in BALB/c mice. J Immunol (1995) 1.00
Antibody responses in patients with staphylococcal septicemia against two Staphylococcus aureus fibrinogen binding proteins: clumping factor and an extracellular fibrinogen binding protein. Clin Diagn Lab Immunol (2000) 1.00
Host factors versus virulence-associated bacterial characteristics in neonatal and infantile bacteraemia and meningitis caused by Escherichia coli. J Med Microbiol (1992) 0.99
Endotoxin-induced alterations in insulin-stimulated phosphorylation of insulin receptor, IRS-1, and MAP kinase in skeletal muscle. Shock (1996) 0.99
Substance P modulates human immunodeficiency virus replication in human peripheral blood monocyte-derived macrophages. AIDS Res Hum Retroviruses (1996) 0.99
PCR reaction and dot-blot hybridization to monitor the distribution of oral pathogens within plaque samples of periodontally healthy individuals. J Periodontol (1996) 0.99
Hyaluronic acid enhances phagocytosis of human monocytes in vitro. J Clin Immunol (1984) 0.98
Multiple interactions between human vitronectin and Staphylococcus aureus. Biochim Biophys Acta (1993) 0.98
Talectomy in patients with recurrent deformity in club foot. A long-term follow-up study. J Bone Joint Surg Br (2001) 0.98
Occurrence of P-fimbriated Escherichia coli in patients with bacteremia. Eur J Clin Microbiol (1985) 0.98
Children with persistent cough--outcome with treatment and role of Moraxella catarrhalis? Scand J Infect Dis (1994) 0.97
Incidence of aerobactin-positive Escherichia coli strains in patients with symptomatic urinary tract infection. Eur J Clin Microbiol Infect Dis (1988) 0.97
Interleukin-8 is a mediator of the final cervical ripening in humans. Eur J Obstet Gynecol Reprod Biol (1997) 0.97
Catechol O-methyltransferase inhibitor tolcapone has minor influence on performance in experimental memory models in rats. Behav Brain Res (1997) 0.97
Isolation and characterisation of a vitronectin-binding surface protein from Staphylococcus aureus. Biochim Biophys Acta (1995) 0.96
Nitroblue tetrazolium (NBT) reduction by bacteria. Some properties of the reaction and its possible use. Acta Pathol Microbiol Scand B (1979) 0.95
Enhanced chemokine response in experimental acute Escherichia coli pyelonephritis in IL-1beta-deficient mice. Clin Exp Immunol (2003) 0.95
Soluble interleukin-1 receptor type II levels are elevated in cerebrospinal fluid in Alzheimer's disease patients. Brain Res (1999) 0.94
Anti-ulcer effect in rats of bitter cardamon constituents. Chem Pharm Bull (Tokyo) (1990) 0.94
The value of immunoelectroosmophoresis (IEOP) for etiological diagnosis of acute respiratory tract infections due to pneumococci and Mycoplasma pneumoniae. Scand J Infect Dis (1978) 0.94
Incidence of the highly conserved fib gene and expression of the fibrinogen-binding (Fib) protein among clinical isolates of Staphylococcus aureus. J Clin Microbiol (1995) 0.94
RecE independent deletions of recombinant plasmids in Bacillus subtilis. Plasmid (1981) 0.93
Biochemical fingerprinting of urinary Escherichia coli causing recurrent infections in women with pyelonephritic renal scarring. Scand J Urol Nephrol (1992) 0.93
Enzyme-linked immunosorbent assay for Escherichia coli heat-stable enterotoxin type II. J Clin Microbiol (1988) 0.93
Experimental neonatal group B streptococcal pneumonia: effect of a modified porcine surfactant on bacterial proliferation in ventilated near-term rabbits. Pediatr Res (1994) 0.92
Downregulatory cytokines in tracheobronchial aspirate fluid from infants with chronic lung disease of prematurity. Acta Paediatr (2000) 0.92
Evaluation of the fluorescent treponemal antibody-absorption (FTA-Abs) test specificity. Acta Derm Venereol (1991) 0.92
Effect of N-acetylcysteine(NAC) treatment on HIV-1 infection: a double-blind placebo-controlled trial. Eur J Clin Pharmacol (1996) 0.92
Reaction of human alveolar macrophages to exposure to Aspergillus fumigatus and inert particles. Environ Res (1997) 0.92
Lipid peroxidation caused by oxygen radicals from Fusobacterium-stimulated neutrophils as a possible model for the emergence of periodontitis. Oral Dis (2001) 0.92
Production of nitric oxide by rat alveolar macrophages stimulated by Cryptococcus neoformans or Aspergillus fumigatus. Med Mycol (1999) 0.92
Heterogeneity of hippocampal GABA(A) receptors: regulation by corticosterone. J Neurosci (2001) 0.92
Functional study of antibodies against a fibrogenin-binding protein in Staphylococcus epidermidis adherence to polyethylene catheters. J Infect Dis (2001) 0.92
Biomechanical and electromyographic evaluation of ankle foot orthosis and dynamic ankle foot orthosis in spastic cerebral palsy. Gait Posture (2004) 0.92
Differential expression patterns of growth-related microRNAs in the skeletal muscle of Nile tilapia (Oreochromis niloticus). J Anim Sci (2012) 0.92
Human monocyte/macrophage response to cobalt-chromium corrosion products and titanium particles in patients with total joint replacements. J Orthop Res (1997) 0.91
Combined evaluation of centromere protein H and Ki-67 as prognostic biomarker for patients with gastric carcinoma. Eur J Surg Oncol (2012) 0.91
Fungal prophylaxis by reduction of fungal colonization by oral administration of bovine anti-Candida antibodies in bone marrow transplant recipients. Bone Marrow Transplant (1999) 0.91
Two new gene cassettes, dfr17 (for trimethoprim resistance) and aadA4 (for spectinomycin/streptomycin resistance), inserted in an Escherichia coli class 1 integron. J Antimicrob Chemother (2000) 0.91
Cytokine gene expression during experimental Escherichia coli pyelonephritis in mice. J Urol (1997) 0.91
High level expression in Escherichia coli of the DNA-binding domain of the glucocorticoid receptor in a functional form utilizing domain-specific cleavage of a fusion protein. J Biol Chem (1989) 0.91
Liposomal antioxidants provide prolonged protection against acute respiratory distress syndrome. Surgery (2000) 0.91
Chimeric animal and plant viruses expressing epitopes of outer membrane protein F as a combined vaccine against Pseudomonas aeruginosa lung infection. FEMS Immunol Med Microbiol (2000) 0.90
Isohelicity and phasing in drug--DNA sequence recognition: crystal structure of a tris(benzimidazole)--oligonucleotide complex. Biochemistry (1996) 0.90